Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

ClinicalTrials.gov ID: NCT00162032

Public ClinicalTrials.gov record NCT00162032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 1:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of CARDIOLITE® Myocardial Perfusion Imaging in Pediatric Subjects With Kawasaki Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Determine the predictive value of CARDIOLITE® rest and stress myocardial perfusion imaging (MPI) to define a pediatric population with Kawasaki Disease (KD) at high and low risk of developing cardiac events.

Study identification

NCT ID
NCT00162032
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lantheus Medical Imaging
Industry
Enrollment
445 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
4 Years to 16 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Apr 30, 2010
Completion
Nov 30, 2010
Last update posted
Jul 22, 2019

2005 – 2010

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Local Institution Anchorage Alaska 99508
Local Institution Little Rock Arkansas 72202
Local Institution Los Angeles California 90027
Local Institution Orange California 92868
Local Institution San Diego California 92123
Local Institution Denver Colorado 80218
Local Institution Hartford Connecticut 06106
Local Institution New Haven Connecticut 06511
Local Institution Honolulu Hawaii 96813
Local Institution Chicago Illinois 60614
Local Institution Chicago Illinois 60637
Local Institution Park Ridge Illinois 60068
Local Institution Indianapolis Indiana 46201
Local Institution Lexington Kentucky 40536
Local Institution Boston Massachusetts 02111
Local Institution Las Vegas Nevada 89109
Local Institution New Hyde Park New York 11040
Local Institution New York New York 10032
Local Institution Durham North Carolina 27710
Local Institution Greenville North Carolina 27858
Local Institution Cincinnati Ohio 45229
Local Institution Cleveland Ohio 44101
Local Institution Hershey Pennsylvania 17033
Local Institution Philadelphia Pennsylvania 19107
Local Institution Pittsburgh Pennsylvania 15213
Local Institution Charlottesville Virginia 22906
Local Institution Seattle Washington 98105
Local Institution Spokane Washington 99204
Local Institution Milwaukee Wisconsin 53203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00162032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2019 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00162032 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →